With his new book, “Nesiritide: The Rise and Fall of Scios,” Roger M. Mills, M.D., aims to inform the general public about the inner workings of the pharmaceutical industry. Specifically, he gives readers an inside look into the development, early success and subsequent demise of a biotechnology drug that he helped to develop.
“‘Nesiritide’” gives the non-medical public an unprecedented insight into the complexity, risk, and competitiveness of drug development,” Mills said. “It demonstrates the devastating impact of media attention to questions of drug safety.”
Before his work at Scios Inc., Miller practiced as an academic clinical cardiologist. He joined Scios, a Johnson & Johnson operating company, in 2005, and layer moved on to Johnson & Johnson’s Janssen Research & Development, LLC as a senior director in clinical research. Since this time, Mills has adopted the mission to better inform the medical community and the public about the often-mysterious pharmaceutical industry.
For more information, visit http://www.rmillsmd.com/.
